Related Experiment Videos

Rhabdomyosarcoma of the biliary tree

Sanz1, de Mingo L, Florez

  • 1Department of Pediatric Surgery, Hospital Nino Jesus, C/Menendez Pelayo 65, E-28009 Madrid, Spain

Insights

Pediatric biliary rhabdomyosarcoma (RMS) is rare and aggressive. Chemotherapy led to complete tumor regression in a child, avoiding extensive surgery and improving survival outcomes.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Pediatric Gastroenterology

Background:

  • Rhabdomyosarcoma (RMS) of the biliary tree is an exceptionally rare pediatric malignancy.
  • This rare tumor often presents with symptoms mimicking choledochal cysts, complicating preoperative diagnosis.
  • Biliary RMS typically carries a very poor prognosis, especially when diagnosed late.

Purpose of the Study:

  • To report a case of pediatric biliary rhabdomyosarcoma (RMS).
  • To highlight the diagnostic challenges and treatment outcomes for this rare condition.
  • To emphasize the potential of neoadjuvant chemotherapy in managing biliary RMS.

Main Methods:

  • Case presentation of a 4-year-old girl with abdominal pain and obstructive jaundice.
  • Diagnosis of biliary rhabdomyosarcoma (RMS) confirmed during exploratory laparotomy.
  • Treatment involved neoadjuvant chemotherapy followed by second-look surgery.

Main Results:

  • Surgical excision was not feasible initially due to tumor size and location.
  • Chemotherapy resulted in complete tumor regression.
  • Second-look surgery confirmed the absence of residual tumor.

Conclusions:

  • Neoadjuvant chemotherapy can achieve complete remission in pediatric biliary rhabdomyosarcoma (RMS).
  • This approach may prevent the need for extensive and potentially disfiguring surgical procedures.
  • Preoperative chemotherapy offers a promising strategy to improve survival rates for biliary RMS.

Related Concept Videos